FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016050715> ?p ?o ?g. }

• W2016050715 endingPage "304" @default.
• W2016050715 startingPage "300" @default.
• W2016050715 abstract "Background Inhaled corticosteroids have become the mainstay of asthma therapy. Few studies however, have compared inhaled steroids in children. We compared the efficacy of inhaled fluticasone propionate (FP), 880 μg/day (2 puffs of 220 μg/puff, BID) with inhaled flunisolide (FLU), 1500 μg/day (3 puffs of 250 μg/puff, BID). Methods Thirty children with moderate to severe asthma, mean age 12.7 years (range 10 to 17 years), mean duration of asthma 8.4 years, initially received flunisolide 1500 μg/day for 1 year, and then were switched to fluticasone propionate 880 μg/day and followed for an additional year. Pulmonary function tests (PFTs) were monitored and analyzed before and after the switch for the duration of study. Mean percent predicted for age values for FVC, FEV 1 , FEF 25-75% , and FEFR were compared at 1 month, 2 to 6-month intervals, and 7 to 12-month intervals and during the same season of the year. Pulmonary function tests within 3 weeks of an exacerbation were not included in the study. The number of asthma exacerbations, emergency room visits, hospital admissions, and number of school days lost were also compared. Results There was significant improvement in mean asthma exacerbations/patient/year (1.7 ± 1.66 SD) versus (4 ± 2.6) ( P P = .004); mean hospital admissions for asthma/patient/year (0.2 ± 0.61) versus (1.13 ± 1.45) ( P P Also, the mean percent values predicted for age in all time-periods (at 1 month, 2 to 6 months, and 7 to 12 months) revealed significant improvement in FEV 1 and FEF 25-75% ( P 1 was observed in all seasons while patients were receiving fluticasone propionate (FP) compared with flunisolide (FLU) ( P 25-75% was observed only in spring and summer season. Conclusion Fluticasone propionate 880 μg/day improved lung function and quality of life in adolescents with moderate-to-severe asthma when compared with flunisolide 1500 μg/day." @default.
• W2016050715 created "2016-06-24" @default.
• W2016050715 creator A5032605150 @default.
• W2016050715 creator A5032767719 @default.
• W2016050715 creator A5065009035 @default.
• W2016050715 creator A5077938430 @default.
• W2016050715 date "1999-10-01" @default.
• W2016050715 modified "2023-10-16" @default.
• W2016050715 title "Comparison of the efficacy of inhaled fluticasone propionate, 880 μg/day, with flunisolide, 1500 μg/day, in moderate-to-severe persistent asthma" @default.
• W2016050715 cites W1611988195 @default.
• W2016050715 cites W1969153504 @default.
• W2016050715 cites W1977466243 @default.
• W2016050715 cites W1987062528 @default.
• W2016050715 cites W1988854276 @default.
• W2016050715 cites W1991902366 @default.
• W2016050715 cites W1992170505 @default.
• W2016050715 cites W1996242416 @default.
• W2016050715 cites W1999493130 @default.
• W2016050715 cites W2068014377 @default.
• W2016050715 cites W2071075398 @default.
• W2016050715 cites W2071302230 @default.
• W2016050715 cites W2088944420 @default.
• W2016050715 cites W2093705266 @default.
• W2016050715 cites W2094440568 @default.
• W2016050715 cites W2098109585 @default.
• W2016050715 cites W2098633046 @default.
• W2016050715 cites W2126699335 @default.
• W2016050715 cites W2157477318 @default.
• W2016050715 cites W2168316735 @default.
• W2016050715 cites W2169843278 @default.
• W2016050715 cites W2172077696 @default.
• W2016050715 cites W2172504657 @default.
• W2016050715 cites W4249821670 @default.
• W2016050715 cites W4368235451 @default.
• W2016050715 doi "https://doi.org/10.1016/s1081-1206(10)62669-5" @default.
• W2016050715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10541421" @default.
• W2016050715 hasPublicationYear "1999" @default.
• W2016050715 type Work @default.
• W2016050715 sameAs 2016050715 @default.
• W2016050715 citedByCount "10" @default.
• W2016050715 crossrefType "journal-article" @default.
• W2016050715 hasAuthorship W2016050715A5032605150 @default.
• W2016050715 hasAuthorship W2016050715A5032767719 @default.
• W2016050715 hasAuthorship W2016050715A5065009035 @default.
• W2016050715 hasAuthorship W2016050715A5077938430 @default.
• W2016050715 hasConcept C126322002 @default.
• W2016050715 hasConcept C187212893 @default.
• W2016050715 hasConcept C2776042228 @default.
• W2016050715 hasConcept C2779028295 @default.
• W2016050715 hasConcept C2781212218 @default.
• W2016050715 hasConcept C42219234 @default.
• W2016050715 hasConcept C71924100 @default.
• W2016050715 hasConceptScore W2016050715C126322002 @default.
• W2016050715 hasConceptScore W2016050715C187212893 @default.
• W2016050715 hasConceptScore W2016050715C2776042228 @default.
• W2016050715 hasConceptScore W2016050715C2779028295 @default.
• W2016050715 hasConceptScore W2016050715C2781212218 @default.
• W2016050715 hasConceptScore W2016050715C42219234 @default.
• W2016050715 hasConceptScore W2016050715C71924100 @default.
• W2016050715 hasIssue "4" @default.
• W2016050715 hasLocation W20160507151 @default.
• W2016050715 hasOpenAccess W2016050715 @default.
• W2016050715 hasPrimaryLocation W20160507151 @default.
• W2016050715 hasRelatedWork W1969372887 @default.
• W2016050715 hasRelatedWork W2027063153 @default.
• W2016050715 hasRelatedWork W2041776764 @default.
• W2016050715 hasRelatedWork W2079098458 @default.
• W2016050715 hasRelatedWork W2082302462 @default.
• W2016050715 hasRelatedWork W2405439450 @default.
• W2016050715 hasRelatedWork W2418865613 @default.
• W2016050715 hasRelatedWork W3035784203 @default.
• W2016050715 hasRelatedWork W3175640025 @default.
• W2016050715 hasRelatedWork W2183642861 @default.
• W2016050715 hasVolume "83" @default.
• W2016050715 isParatext "false" @default.
• W2016050715 isRetracted "false" @default.
• W2016050715 magId "2016050715" @default.
• W2016050715 workType "article" @default.